Also, INT-767 has been shown to alleviate hypercholesterolemia and increase the expression of thermogenic genes through FXR and/or TGR5 activation, leading to the reversal of HFD-induced metabolic disorders (Jadhav et al., 2018). This evidence concerns the gene NR1H4 and Hypercholesterolemia.